OBJECTIVE: Human beta-defensin-2 (HBD-2) is a potent antimicrobial peptide that is part of the innate immune response. The purpose of this study was to determine whether HBD-2 is present in amniotic fluid and if its concentration changes with microbial invasion of the amniotic cavity (MIAC) and labor. STUDY DESIGN: Amniotic fluid was retrieved by amniocentesis from 318 patients in the following groups: (1) mid-trimester (n=75); (2) term not in labor (n=28) and in labor (n=51); (3) preterm labor and intact membranes without MIAC who delivered at term (n=36), who delivered preterm without MIAC (n=52), and preterm labor with MIAC who delivered preterm (n=25); and (4) preterm premature rupture of membranes (preterm PROM) with (n=25) and without MIAC (n=26). MIAC was defined as a positive amniotic fluid culture for microorganisms. Amniotic fluid HBD-2 concentrations were determined using a sensitive and specific ELISA. Non-parametric statistics were used for analysis. RESULTS: (1) HBD-2 was detected in all amniotic fluid samples; (2) the concentration of HBD-2 did not change with gestational age from mid-trimester to term (p=0.8); (3) intra-amniotic infection was associated with a significant increase in amniotic fluid concentrations of HBD-2 in both women with preterm labor and intact membranes, and women with preterm PROM (p<0.05 for each comparison); (4) patients with preterm labor and a negative amniotic fluid culture who delivered preterm had a higher median amniotic fluid HBD-2 concentration than those with preterm labor who delivered at term (p=0.001); and (5) among patients with preterm labor without MIAC, those who had intra-amniotic inflammation (amniotic fluid white blood cell count>100 cells per mL) had a higher median amniotic fluid concentration of HBD-2 than those without this condition (p<0.002). CONCLUSION: (1) Amniotic fluid contains HBD-2, a natural antimicrobial peptide, and this may account for some of the antimicrobial activity of amniotic fluid; (2) amniotic fluid HBD-2 concentrations are increased in women with MIAC, regardless of the membrane status (intact membranes or PROM); and (3) we propose that amniotic fluid HBD-2 is part of the innate immune system within the amniotic cavity.
OBJECTIVE:Humanbeta-defensin-2 (HBD-2) is a potent antimicrobial peptide that is part of the innate immune response. The purpose of this study was to determine whether HBD-2 is present in amniotic fluid and if its concentration changes with microbial invasion of the amniotic cavity (MIAC) and labor. STUDY DESIGN: Amniotic fluid was retrieved by amniocentesis from 318 patients in the following groups: (1) mid-trimester (n=75); (2) term not in labor (n=28) and in labor (n=51); (3) preterm labor and intact membranes without MIAC who delivered at term (n=36), who delivered preterm without MIAC (n=52), and preterm labor with MIAC who delivered preterm (n=25); and (4) preterm premature rupture of membranes (preterm PROM) with (n=25) and without MIAC (n=26). MIAC was defined as a positive amniotic fluid culture for microorganisms. Amniotic fluid HBD-2 concentrations were determined using a sensitive and specific ELISA. Non-parametric statistics were used for analysis. RESULTS: (1) HBD-2 was detected in all amniotic fluid samples; (2) the concentration of HBD-2 did not change with gestational age from mid-trimester to term (p=0.8); (3) intra-amniotic infection was associated with a significant increase in amniotic fluid concentrations of HBD-2 in both women with preterm labor and intact membranes, and women with preterm PROM (p<0.05 for each comparison); (4) patients with preterm labor and a negative amniotic fluid culture who delivered preterm had a higher median amniotic fluid HBD-2 concentration than those with preterm labor who delivered at term (p=0.001); and (5) among patients with preterm labor without MIAC, those who had intra-amniotic inflammation (amniotic fluid white blood cell count>100 cells per mL) had a higher median amniotic fluid concentration of HBD-2 than those without this condition (p<0.002). CONCLUSION: (1) Amniotic fluid contains HBD-2, a natural antimicrobial peptide, and this may account for some of the antimicrobial activity of amniotic fluid; (2) amniotic fluid HBD-2 concentrations are increased in women with MIAC, regardless of the membrane status (intact membranes or PROM); and (3) we propose that amniotic fluid HBD-2 is part of the innate immune system within the amniotic cavity.
Authors: J Harder; U Meyer-Hoffert; L M Teran; L Schwichtenberg; J Bartels; S Maune; J M Schröder Journal: Am J Respir Cell Mol Biol Date: 2000-06 Impact factor: 6.914
Authors: D M Hoover; K R Rajashankar; R Blumenthal; A Puri; J J Oppenheim; O Chertov; J Lubkowski Journal: J Biol Chem Date: 2000-10-20 Impact factor: 5.157
Authors: Josef Johann Schneider; Angela Unholzer; Martin Schaller; Monika Schäfer-Korting; Hans Christian Korting Journal: J Mol Med (Berl) Date: 2005-04-09 Impact factor: 4.599
Authors: N Kjaergaard; M Hein; L Hyttel; R B Helmig; H C Schønheyder; N Uldbjerg; H Madsen Journal: Eur J Obstet Gynecol Reprod Biol Date: 2001-02 Impact factor: 2.435
Authors: Roberto Romero; Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Stanley M Berry; Juan Pedro Kusanovic; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor Journal: J Perinat Med Date: 2011-09-30 Impact factor: 1.901
Authors: Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher Journal: J Matern Fetal Neonatal Med Date: 2010-05-26
Authors: R Romero; J P Kusanovic; J Espinoza; F Gotsch; C L Nhan-Chang; O Erez; C J Kim; N Khalek; P Mittal; L F Goncalves; C Schaudinn; S S Hassan; J W Costerton Journal: Ultrasound Obstet Gynecol Date: 2007-10 Impact factor: 7.299
Authors: Roberto Romero; Juan Pedro Kusanovic; Hernan Muñoz; Ricardo Gomez; Ronald F Lamont; Lami Yeo Journal: J Matern Fetal Neonatal Med Date: 2010-04
Authors: Roberto Romero; Juan Pedro Kusanovic; Ricardo Gomez; Ronald Lamont; Egle Bytautiene; Robert E Garfield; Pooja Mittal; Sonia S Hassan; Lami Yeo Journal: J Matern Fetal Neonatal Med Date: 2010-04
Authors: Roberto Romero; Eleazar Soto; Stanley M Berry; Sonia S Hassan; Juan Pedro Kusanovic; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor; Tinnakorn Chaiworapongsa Journal: J Matern Fetal Neonatal Med Date: 2011-12-20
Authors: Sally A Madsen-Bouterse; Roberto Romero; Adi L Tarca; Juan Pedro Kusanovic; Jimmy Espinoza; Chong Jai Kim; Jung-Sun Kim; Samuel S Edwin; Ricardo Gomez; Sorin Draghici Journal: Am J Reprod Immunol Date: 2010-01 Impact factor: 3.886
Authors: Pooja Mittal; Roberto Romero; Juan Pedro Kusanovic; Samuel S Edwin; Francesca Gotsch; Shali Mazaki-Tovi; Jimmy Espinoza; Offer Erez; Chia-Ling Nhan-Chang; Nandor G Than; Edi Vaisbuch; Sonia S Hassan Journal: Am J Reprod Immunol Date: 2008-09 Impact factor: 3.886